To understand if the association between TSPO expression and patient survival simply reflected the association with WHO grade, Mittienen et al. [54] looked separately at the WHO grade II astrocytomas group and confirmed that lesions with higher TSPO had a tendency for shorter survival time. This evidence concerns the gene TSPO and astrocytoma (excluding glioblastoma).